{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:01:02Z","timestamp":1774353662245,"version":"3.50.1"},"reference-count":42,"publisher":"IOP Publishing","issue":"3","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biomed. Mater."],"published-print":{"date-parts":[[2021,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The advent of tyrosine kinase inhibitors in the therapeutic protocols of chronic myeloid leukemia (CML) was a revolution in the treatment strategies that guaranteed the achievement of complete remission for patients. However, due to different mutations bypassing the efficacy of Imatinib, novel and more effective treatments are indeed required for the treatment of CML. Our study declared that the combination of synthesized ZnO\/CNT@Fe\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    nanocomposite with Imatinib decreased survival of CML-derived K562 cells, probably through inducing reactive oxygen species-mediated apoptosis. We also found improved cytotoxicity in the presence of a well known autophagy inhibitor, indicating that the apoptotic effect of this treatment is enhanced via autophagy suppression. Investigating the molecular mechanisms for the growth-suppressive effect of ZnO\/CNT@Fe\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    -plus-Imatinib suggested that up-regulation of SIRT1 ceased cell cycle progression by increasing the expression of p21 and p27 cyclin-dependent kinase inhibitors. Notably, we reported here for the first time that either direct or indirect suppression of c-Myc results in enhanced anti-leukemic efficacy, suggesting that overexpression of c-Myc plays a contributory role in attenuating the efficacy of ZnO\/CNT@Fe\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    \u2014Imatinib in K562 cells. Given the promising effect of ZnO\/CNT@Fe\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    in potentiating the anti-cancer effects of Imatinib in K562 cells, our study suggested that nanocomposite could be used as a tool for combined-strategy treatment. However, further\n                    <jats:italic>in vivo<\/jats:italic>\n                    experiments are needed to provide clues for the safety and efficacy of this nanocomposite.\n                  <\/jats:p>","DOI":"10.1088\/1748-605x\/abcae2","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T17:31:17Z","timestamp":1605547877000},"page":"035029","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Application of ZnO\/CNT@Fe\n                    <sub>3<\/sub>\n                    O\n                    <sub>4<\/sub>\n                    nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia"],"prefix":"10.1088","volume":"16","author":[{"given":"Amir-Mohammad","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ava","family":"Safaroghli-Azar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atieh","family":"Pourbagheri-Sigaroodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Fakhroueian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Momeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-4920","authenticated-orcid":false,"given":"Davood","family":"Bashash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"bmmabcae2bib1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13054-017-1678-1","type":"journal-article","article-title":"New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management","volume":"21","author":"Kroschinsky","year":"2017","journal-title":"Crit. Care"},{"key":"bmmabcae2bib2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3892\/or.2017.5718","type":"journal-article","article-title":"Cancer drug delivery in the nano era: an overview and perspectives","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"bmmabcae2bib3","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/304\/1\/012046","type":"journal-article","article-title":"Cytotoxicity effects of metal oxide nanoparticles in human tumor cell lines","volume":"304","author":"Lozano","year":"2011","journal-title":"J. Phys. Conf. Ser."},{"key":"bmmabcae2bib4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/751075","type":"journal-article","article-title":"Noble metal nanoparticles applications in cancer","volume":"2012","author":"Conde","year":"2012","journal-title":"J. Drug Deliv."},{"key":"bmmabcae2bib5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/nano8040268","type":"journal-article","article-title":"ZnO nanostructures for drug delivery and theranostic applications","volume":"8","author":"Mart\u00ednez-Carmona","year":"2018","journal-title":"Nanomaterials"},{"key":"bmmabcae2bib6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jbm.a.30901","type":"journal-article","article-title":"The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance","volume":"80","author":"Wang","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"bmmabcae2bib7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/21691401.2018.1452023","type":"journal-article","article-title":"ZnO Q-dots as a potent therapeutic nanomedicine for in vitro cytotoxicity evaluation of mouth KB44, breast MCF7, colon HT29 and HeLa cancer cell lines, mouse ear swelling tests in vivo and its side effects using the animal model","volume":"46","author":"Fakhroueian","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"bmmabcae2bib8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1166\/jnn.2017.13046","type":"journal-article","article-title":"Toxicity evaluation of iron oxide (Fe3O4) nanoparticles on human neuroblastoma-derived SH-SY5Y cell line","volume":"17","author":"Ram\u00edrez-Cando","year":"2017","journal-title":"J. Nanosci. Nanotechnol."},{"key":"bmmabcae2bib9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s11671-016-1734-9","type":"journal-article","article-title":"Synthesis, characterization, and study of in vitro cytotoxicity of ZnO-Fe3O4 magnetic composite nanoparticles in human breast cancer cell line (MDA-MB-231) and mouse fibroblast (NIH 3T3)","volume":"11","author":"Bisht","year":"2016","journal-title":"Nanoscale Res. Lett."},{"key":"bmmabcae2bib10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s11671-015-0920-5","type":"journal-article","article-title":"Fabrication of Fe 3 O 4@ mSiO 2 core-shell composite nanoparticles for drug delivery applications","volume":"10","author":"Madrid","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"bmmabcae2bib11","first-page":"845","type":"journal-article","article-title":"Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species","volume":"7","author":"Akhtar","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"bmmabcae2bib12","first-page":"135","type":"journal-article","article-title":"Hexavalent chromium treatment by high adsorption magnetite (Fe 3 O 4) nanoparticle","volume":"3","author":"Aftabtalab","year":"2013","journal-title":"Int. J. Therm. Technol."},{"key":"bmmabcae2bib13","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s10853-006-0763-7","type":"journal-article","article-title":"Synthesis by the solution combustion process and magnetic properties of iron oxide (Fe 3 O 4 and \u03b1-Fe 2 O 3) particles","volume":"42","author":"Toniolo","year":"2007","journal-title":"J. Mater. Sci."},{"key":"bmmabcae2bib14","first-page":"41","type":"web-resource","article-title":"Synthesis and formulation of powerful ZnO Q-dots\/CNTs@Fe3O4 nanopackage as a predominant anti-HIV-1 infection","volume":"5","author":"Fakhroueian","year":"2020"},{"key":"bmmabcae2bib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2020.125860","type":"journal-article","article-title":"Designing a novel targeted-release nano-container based on the silanized graphene oxide decorated with cerium acetylacetonate loaded beta-cyclodextrin (\u03b2-CD-CeA-MGO) for epoxy anti-corrosion coating","volume":"400","author":"Dehghani","year":"2020","journal-title":"Chem. Eng. J."},{"key":"bmmabcae2bib16","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2020.125061","type":"journal-article","article-title":"Non-covalently surface modification of graphene oxide nanosheets and its role in the enhancement of the epoxy-based coatingsphysical properties","volume":"602","author":"Javidparvar","year":"2020","journal-title":"Colloids Surf. A"},{"key":"bmmabcae2bib17","doi-asserted-by":"publisher","DOI":"10.1038\/srep43181","type":"journal-article","article-title":"Phthalocyanine doped metal oxide nanoparticles on multiwalled carbon nanotubes platform for the detection of dopamine","volume":"7","author":"Mphuthi","year":"2017","journal-title":"Sci. Rep."},{"key":"bmmabcae2bib18","doi-asserted-by":"publisher","first-page":"24962","DOI":"10.1039\/C4RA03158J","type":"journal-article","article-title":"Synthesis of ZnO\/Au and ZnO\/Ag nanoparticles and their photocatalytic application using UV and visible light","volume":"4","author":"Fageria","year":"2014","journal-title":"RSC Adv."},{"key":"bmmabcae2bib19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.112751","type":"journal-article","article-title":"Studying the adsorption\/inhibition impact of the cellulose and lignin compounds extracted from agricultural waste on the mild steel corrosion in HCl solution","volume":"304","author":"Shahmoradi","year":"2020","journal-title":"J. Mol. Liq."},{"key":"bmmabcae2bib20","doi-asserted-by":"publisher","DOI":"10.29252\/ibj.25.1.8","type":"journal-article","article-title":"Developing a fluorescent hybrid nanobiosensor based on quantum dots and azoreductase enzyme forMethyl red monitoring","volume":"25","author":"Hajipour","year":"2021","journal-title":"Iran. Biomed. J."},{"key":"bmmabcae2bib21","first-page":"395","type":"web-resource","article-title":"Spectroscopic characterization of chloramphenicol and tetracycline: an impact of biofield treatment","volume":"6","author":"Trivedi","year":"2015"},{"key":"bmmabcae2bib22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7508\/jns.2012.04.002","type":"journal-article","article-title":"Synthesize of superparamagnetic zinc ferrite nanoparticles at room temperature","volume":"2","author":"Raeisi Shahraki","year":"2012","journal-title":"J. Nanostruct."},{"key":"bmmabcae2bib23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ajh.24249","type":"journal-article","article-title":"Chronic myeloid leukemia: first\u2010line drug of choice","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am. J. Hematol."},{"key":"bmmabcae2bib24","doi-asserted-by":"publisher","first-page":"BMI. S","DOI":"10.4137\/BMI.S22431","type":"journal-article","article-title":"Management of chronic myeloid leukemia patients resistant to tyrosine kinase inhibitors treatment","volume":"10","author":"Wieczorek","year":"2015","journal-title":"Biomark. Insights"},{"key":"bmmabcae2bib25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1021\/ml500091p","type":"book","author":"Cui","year":"2014"},{"key":"bmmabcae2bib26","first-page":"1","type":"journal-article","article-title":"Mechanism of oxidative stress involved in the toxicity of ZnO nanoparticles against eukaryotic cells","volume":"3","author":"Saliani","year":"2016","journal-title":"Nanomed. J."},{"key":"bmmabcae2bib27","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/593014","type":"journal-article","article-title":"Cytotoxic effects of biosynthesized zinc oxide nanoparticles on murine cell lines","volume":"2015","author":"Namvar","year":"2015","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"bmmabcae2bib28","first-page":"231","type":"web-resource","article-title":"The role of c-Myc protooncogene in chronic myelogenous leukemia","volume":"32","author":"Nieborowska-Skorska","year":"1994"},{"key":"bmmabcae2bib29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-015-0407-0","type":"journal-article","article-title":"BCR\/ABL1 and BCR are under the transcriptional control of the MYC oncogene","volume":"14","author":"Sharma","year":"2015","journal-title":"Mol. Cancer"},{"key":"bmmabcae2bib30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.hoc.2017.04.007","type":"journal-article","article-title":"Mechanisms of resistance to ABL kinase inhibition in chronic myeloid leukemia and the development of next generation ABL kinase inhibitors","volume":"31","author":"Patel","year":"2017","journal-title":"Hematol. Oncol. Clin."},{"key":"bmmabcae2bib31","doi-asserted-by":"publisher","DOI":"10.4161\/23723556.2014.985913","type":"journal-article","article-title":"Autophagy, cell death, and cancer","volume":"2","author":"Lin","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"bmmabcae2bib32","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/ijms19113466","type":"journal-article","article-title":"The roles of autophagy in cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"bmmabcae2bib33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/PPO.0b013e318237e5b7","type":"journal-article","article-title":"Development of an effective therapy for CML","volume":"17","author":"Woessner","year":"2011","journal-title":"Cancer J."},{"key":"bmmabcae2bib34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.acr.2017.11.003","type":"book","volume":"vol","author":"Amreddy","year":"2018"},{"key":"bmmabcae2bib35","doi-asserted-by":"publisher","DOI":"10.1088\/1612-202X\/aad28c","type":"journal-article","article-title":"Development and imaging of zinc oxide nanorods as a photosensitizer for the diagnosis and treatment of cancer using lasers","volume":"15","author":"Firdous","year":"2018","journal-title":"Laser Phys. Lett."},{"key":"bmmabcae2bib36","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1021\/tx500113u","type":"journal-article","article-title":"Preparation, characterization, cytotoxicity, and genotoxicity evaluations of thiolated-and S-nitrosated superparamagnetic iron oxide nanoparticles: implications for cancer treatment","volume":"27","author":"Seabra","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"bmmabcae2bib37","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/21691401.2020.1748885","type":"journal-article","article-title":"ZnO\/CNT@ Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment","volume":"48","author":"Yousefi","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"bmmabcae2bib38","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.2147\/IJN.S140071","type":"journal-article","article-title":"Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells","volume":"12","author":"Bai","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"bmmabcae2bib39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/bjc.2013.40","type":"journal-article","article-title":"Oxidative stress specifically downregulates survivin to promote breast tumour formation","volume":"108","author":"Pervin","year":"2013","journal-title":"Br. J. Cancer"},{"key":"bmmabcae2bib40","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3892\/ijo.2014.2313","type":"journal-article","article-title":"Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia","volume":"44","author":"Shao","year":"2014","journal-title":"Int. J. Oncol."},{"key":"bmmabcae2bib41","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.1002\/jcb.28675","type":"journal-article","article-title":"Suppression of c\u2010Myc using 10058\u2010F4 exerts caspase\u20103\u2010dependent apoptosis and intensifies the antileukemic effect of vincristine in pre\u2010B acute lymphoblastic leukemia cells","volume":"120","author":"Sheikh\u2010Zeineddini","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"bmmabcae2bib42","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/cbin.11322","type":"journal-article","article-title":"Anti\u2010leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c\u2010Myc and autophagy on BKM120 cytotoxicity","volume":"44","author":"Shiri Heris","year":"2020","journal-title":"Cell Biol. Int."}],"container-title":["Biomedical Materials"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T13:26:37Z","timestamp":1765027597000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/abcae2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,5]]},"published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1748-605x\/abcae2","relation":{},"ISSN":["1748-6041","1748-605X"],"issn-type":[{"value":"1748-6041","type":"print"},{"value":"1748-605X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"Application of ZnO\/CNT@Fe\n                      3\n                      O\n                      4\n                      nanocomposite in amplifying the anti-leukemic effects of Imatinib: a novel strategy to adjuvant therapy in chronic myeloid leukemia","name":"article_title","label":"Article Title"},{"value":"Biomedical Materials","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2021 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2020-05-19","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2020-11-16","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2021-03-05","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}